I know the newsletter usually lands on Sunday, but last week I was on the road. Miami, Palm Beach, Boston. Meeting doctors where they practice, seeing their world, listening. I took a moment to step back, process, and reflect. The conversations were real, docs shared their challenges and I want to share them with you.
Here we go.
Dr. David Luu - Founder, longevity docs.™
Each week, I try to explore one idea that could advance longevity medicine and hopefully support physicians in bringing it to life.
Last week, I met with 25 physicians passionate about evidence-based longevity medicine. What I heard wasn’t about the promising interventions, it was about the reality of building a new field from scratch.
Here’s what’s keeping them up at night:
1. Patient Understanding & Expectations Patients arrive armed with acronyms (NAD, GLP-1, VO₂ max) but lack understanding of foundational principles. Most still expect insurance coverage for preventive optimization, creating friction before care even begins.
2. Trust & Credibility The field is flooded with influencers, wellness entrepreneurs, and practitioners of varying credibility. Patients can’t easily distinguish evidence-based medicine from expensive pseudoscience, and serious physicians bear the reputational cost.
3. Standard of Care & Clinical Protocols Little consensus exists on which biomarkers matter, what testing sequence makes sense, or which interventions have sufficient evidence. Every clinic is creating its own playbook.
4. Access & Affordability Annual programs range from $100 to $250,000. Most doctors entered medicine to help people, not to serve exclusively the ultra-wealthy. They’re searching for scalable models that expand access without compromising quality.
5. Clinic Identity & Positioning The transition from “treating disease” to “optimizing healthspan” requires entirely new language. Doctors trained in pathology now need to articulate value propositions around performance, prevention, and delayed decline.
6. Pricing, Packaging & Scale Should you charge per test? Per visit? Annual retainer? How do you grow without becoming an absentee physician or hiring inexperienced providers? No established business model exists.
7. Team Recruitment & Training Finding staff who understand advanced diagnostics, can interpret complex biomarker panels, and deliver premium patient experiences is nearly impossible. Training programs don’t exist. Retention is a constant challenge.
8. Regulation & Compliance Off-label prescribing, novel diagnostics, cash-pay models, and interstate telemedicine create a minefield of legal and regulatory risk. Most doctors are navigating this alone, without clear guidance.
9. Research Participation Physicians want to contribute to the evidence base, not just consume it. They’re generating real-world data daily but lack infrastructure to participate in meaningful research or registries.
10. Tech & AI Literacy Wearables, multi-omics, continuous glucose monitors, AI diagnostics: the tools are proliferating faster than clinical understanding. Doctors want practical training, not vendor pitches or hype cycles.
Longevity medicine is still in its early stage and that’s the opportunity. We are building this field in real time. The clinical standards, the operational models, the regulatory frameworks, the education, none of it exists yet at scale. And that’s exactly why physicians feel both excited and cautious.
What I heard this week is simple: doctors want to practice good medicine, expand access beyond the ultra-wealthy, and build something sustainable. They want to enjoy their work again.
Every week, the longevitydocs WhatsApp group feels like a front-row seat to the future of medicine. Here’s what had doctors buzzing:
Originally published in The Longevity Medicine Intelligence newsletter (Issue 70).
